Jeong, C.S
FDA prescribing information for some GLP-1 receptor agonists (particularly those approved for weight management) includes recommendations to monitor heart rate at regular intervals and consider discontinuation for sustained increases in resting heart rate
12 note
There were three dominant classes representing 87.2% and 87.8% of males (classes 1, 2, and 5) and females (classes 2, 3, and 4), respectively, in the BHS and four dominant classes representing 93.5% of females (classes 1, 2, 7, and 8) and 89.5% of males (classes 1, 5, 6, and 7) in the NHANES population
So what we do is we take a naturally occurring hormone, we take it out, synthesize it into pharmacologic amounts, give it back to individuals, so we're able to amplify these satiety signals that someone's not quite getting, so they feel full
Incretin pharmacology: a review of the incretin effect and current incretin-based therapies